ALHC Alignment Healthcare, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Alignment Healthcare, Inc. (ALHC) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 27, 2026, a 10-Q quarterly report filed on April 30, 2026, an 8-K current report filed on July 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Alignment Healthcare, Inc. (ALHC) (SEC CIK 1832466), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Consumer-centric Medicare Advantage plans focused on coordinated, proactive care for seniors using integrated clinical and technology platform
- • Emphasized this year: Expanded "Care Anywhere" in-house clinician-driven care model providing free, personalized at-home and virtual chronic condition management
- • Strategic shift: Greater investment in internal clinical staff (450 FTEs, 25% workforce) to reduce hospitalizations and improve outcomes via direct care delivery
- • Quantitative growth: Health Plan Membership reached 236,300 at 30% CAGR since inception with revenue 5-year CAGR of 36% through 2025
- • Noteworthy fact: Proprietary AVA platform integrates data from 200+ sources using AI for real-time, prescriptive care insights enhancing member and provider workflows
Risk Factors
- • Regulatory risk: potential loss/suspension of CMS Medicare Advantage contracts affecting revenue source
- • Macroeconomic threat: geographic concentration in few U.S. states limits expansion, increasing exposure to regional market downturns
- • Operational vulnerability: dependency on AVA AI platform for clinical initiatives poses risk of regulatory and operational setbacks
- • Competitive risk: competition for physician networks intensifies due to healthcare industry consolidation with better-resourced plans
- • Financial risk: accumulated deficit $1,009.0 million as of 12/31/2025 with net loss $1.0 million in 2025, $128.1 million in 2024
Management Discussion & Analysis
- • Revenue $3.949B, up 46.1% YoY; earned premiums $3.912B, +46.4% driven by 25% membership growth to 236,300 and higher PMPM rates
- • Operating income $14.8M vs loss $101.6M; operating margin 0.4% vs (3.7)% in prior year
- • Medical expenses segment largest, 87.6% of revenue vs 89.0%, MBR improved to 87.5% from 88.8%
- • Adjusted EBITDA $109.9M vs $1.3M; adjusted gross profit $494.8M, up 63.5%
- • No cash flow/capital allocation specifics provided; mention of continued investments, accelerated sales and marketing expenses, and growth investments
- • Management outlook: focus on expanding membership (275,300 Health Plan Members as of Jan 1, 2026), new market entry, investing in AVA platform, strong CMS star ratings support financial incentives and sustainable growth
Go deeper on Alignment Healthcare, Inc.
Ask AI about ALHC filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting ALHC positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on ALHC.
Annual Reports Archive10-K
AI-powered analysis of Alignment Healthcare, Inc. (ALHC) 10-K annual reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Alignment Healthcare, Inc. (ALHC) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $2.7B | $3.9B |
| Operating Income | - | -$101.6M | $14.8M |
| Net Income | -$148.0M | -$128.0M | -$724K |
| Op. Margin | - | -3.8% | 0.4% |
| Net Margin | - | -4.7% | -0.0% |
| Balance Sheet | |||
| Total Assets | $591.9M | $782.1M | $1.1B |
| Equity | - | $99.9M | $179.3M |
| ROE | - | -128.2% | -0.4% |
| Per Share | |||
| EPS | $-0.79 | $-0.67 | $0.00 |
| Cash Flow | |||
| Operating CF | -$59.2M | $34.8M | $139.9M |
| CapEx | - | $41.4M | $26.8M |
Source: XBRL financial data from Alignment Healthcare, Inc. (ALHC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 30, 2026 | - | - | - |
8-K | Jun 9, 2026 | - | - | |
8-K | May 12, 2026 | - | - | |
8-K | Apr 30, 2026 | - | - | - |
10-Q | Apr 30, 2026 | Mar 31, 2026 | - | |
8-K | Mar 4, 2026 | - | Analysis | - |
10-K | Feb 27, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 26, 2026 | - | Analysis | - |
8-K | Jan 12, 2026 | - | - | |
10-Q | Oct 30, 2025 | Sep 30, 2025 | - | |
10-Q | Jul 30, 2025 | Jun 30, 2025 | - | |
10-Q | May 1, 2025 | Mar 31, 2025 | - | |
10-K | Feb 27, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 4, 2024 | - | - | |
10-Q | Oct 29, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 1, 2024 | Jun 30, 2024 | - | |
SC 13G | May 17, 2024 | - | - | |
10-Q | May 2, 2024 | Mar 31, 2024 | - | |
10-K | Feb 27, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 14, 2024 | - | - | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | - | |
10-Q | May 4, 2023 | Mar 31, 2023 | - | |
10-K | Feb 28, 2023 | Dec 31, 2022 | - | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate ALHC share value held by 13F filers tracked by SignalX, by quarter.
- BNY Mellon+2.32M (+233%)
- Bank of America Corp+1.96M (+156%)
- Millennium Management+1.34M (+52%)
- FMR LLC (Fidelity)+1.24M (+8%)
- Citadel Advisors LLC+771.2K (+16%)
- Morgan Stanley835.7K (-35%)
- Prudential Financial150.7K (-31%)
- Goldman Sachs Group140.8K (-12%)
- D.E. Shaw & Co132.9K (-54%)
- Wells Fargo & Co107.5K (-56%)
- Franklin Resources+113.9K
- Truist Financial+57.5K
- Dimensional Fund Advisors+46.5K
- Blackstone Group+28.6K
- Fifth Third Bancorp+6.9K
- Vanguard Group Inc−15.49M
- Invesco Ltd−6.20M
- JPMorgan Chase & Co−125.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 174 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest ALHC SEC filings in 2026?
Alignment Healthcare, Inc. (ALHC) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on July 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ALHC file its most recent 10-K annual report?
Alignment Healthcare, Inc. (ALHC) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ALHC 10-Q quarterly reports?
Alignment Healthcare, Inc. (ALHC)'s most recent 10-Q quarterly report was filed on April 30, 2026. SignalX displays every ALHC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ALHC filed recently?
Alignment Healthcare, Inc. (ALHC)'s most recent 8-K was filed on July 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ALHC insider trading activity (Form 4)?
SignalX aggregates every ALHC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ALHC file with the SEC?
Alignment Healthcare, Inc. (ALHC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ALHC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Alignment Healthcare, Inc. (ALHC).
What is ALHC's SEC CIK number?
Alignment Healthcare, Inc. (ALHC)'s SEC CIK (Central Index Key) number is 1832466. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1832466 to look up all ALHC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ALHC return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Alignment Healthcare, Inc. (ALHC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Alignment Healthcare, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 34+ filings.